Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Traitement des vascularites vers un monde sans corticoïde Pr Divi CORNEC, BrestCOFERPhoto : Aodhanbzh, CC BY-SA 4.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Divi Cornec ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Divi Cornec est rhumatologue à Brest (29609). Il consulte à CHRU BREST SITE HOPITAL CAVALE BLANCHE, Boulevard TANGUY PRIGENT, 29609 Brest.
Consulter
CHRU BREST SITE HOPITAL CAVALE BLANCHE
Boulevard TANGUY PRIGENT, 29609 Brest
Dr Divi Cornec, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2025The Lancet. Rheumatology55 citations
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2024Arthritis & rheumatology (Hoboken, N.J.)34 citations
Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation
2023The Lancet. Rheumatology27 citations
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Divi Cornec consulte à CHRU BREST SITE HOPITAL CAVALE BLANCHE, Boulevard TANGUY PRIGENT, 29609 Brest. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 02 98 22 33 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Brest, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Interferon-α-Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double-Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease
2026Joint bone spinePubMed
Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2025Annals of the rheumatic diseasesPubMed
GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica
2025The Lancet. RheumatologyPubMed
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
2024European journal of nuclear medicine and molecular imagingPubMed
[(18)F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
2024RMD openPubMed
Concordance and agreement between different activity scores in polymyalgia rheumatica
2023The Lancet. RheumatologyPubMed
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
2026Laboratory investigation; a journal of technical methods and pathologyPubMed
Advancing Multiplex Imaging: A Sequential Antigen Retrieval Protocol to Enhance Antibody Compatibility and Detection Sensitivity
2026The Journal of investigative dermatologyPubMed
B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non-drug-related lichen planus
2026Laboratory investigation; a journal of technical methods and pathologyPubMed
Optimal Formalin-Fixed Paraffin-Embedded Sample Preservation for Efficient Staining in Multiplex Imaging
2025La Revue de medecine internePubMed
[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]
2025The Lancet. RheumatologyPubMed
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2024Journal of autoimmunityPubMed
Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow
2024Arthritis & rheumatology (Hoboken, N.J.)PubMed
Reply
2026Annals of the rheumatic diseasesPubMed
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2024European journal of nuclear medicine and molecular imagingPubMed
[(18)F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
2023The Lancet. RheumatologyPubMed
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
2026The Lancet. RheumatologyPubMed
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
2026Joint bone spinePubMed
Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
2025Frontiers in medicinePubMed
Commentary: Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort
2025Joint bone spinePubMed
Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis
2025La Revue de medecine internePubMed
[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus]
2024Clinical immunology (Orlando, Fla.)PubMed
Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus
2024Database : the journal of biological databases and curationPubMed
An interactive web application for exploring systemic lupus erythematosus blood transcriptomic diversity
2026Joint bone spinePubMed
Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
2025The Lancet. RheumatologyPubMed
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
2026Rheumatology (Oxford, England)PubMed
The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease
2025Rheumatology (Oxford, England)PubMed
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
2026Immunological reviewsPubMed
Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity
2026Joint bone spinePubMed
Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
2026Immunological reviewsPubMed
Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity
2026Joint bone spinePubMed
Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
2026 · Article
Single-Cell Spatial Transcriptomic of Sjögren’s Disease Salivary Glands
2026 · Article
Advancing Multiplex Imaging: A Sequential Antigen Retrieval Protocol to Enhance Antibody Compatibility and Detection Sensitivity
2026 · Article
Sustained low disease activity during long-term mepolizumab treatment in FIP1L1::PDGFRA-negative hypereosinophilic syndrome: a multicenter real-world study
2026 · Article
Interferon‐α–Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double‐Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease
2026 · Article
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study
2026 · Article
B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non–drug-related lichen planus
2026 · Article
Inflammation‐Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity
2026 · Article
Patients’ perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2021 · doctorant : Nedra Chriti
Caractérisation des lymphocytes B auto-réactifs dans le syndrome de Sjögren
— · doctorant : Rudolf Corty
PreSSto - Pre-Sjögren Syndrome Targeted Immunology Evaluation
— · doctorant : Alice Tison
Study of the immune mechanisms leading to rheumatic immune related adverse events occuring with Immune Checkpoint Inhibitors.